Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn New India Regulatory News (ANII)

Share Price Information for Abrdn New India (ANII)

Share Price is delayed by 15 minutes
Get Live Data
664.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (0.904%)
Market Cap: £287.76m
ANII Live PriceLast checked at - London Stock Exchange

Intraday Abrdn New India Share Chart

Directorate Changes

1 Apr 2026 07:00

RNS Number : 9243Y
Aberdeen New India Investment Trust
01 April 2026
 

ABERDEEN NEW INDIA INVESTMENT TRUST PLC

LEI - 549300D2AW66WYEVKF02

 

 

1 April 2026

 

Appointment of Non-Executive Director

 

The Board of Aberdeen New India Investment Trust PLC (the "Company") is pleased to announce the appointment of Francesca Ecsery as an independent non-executive Director of the Company with effect from 1 April 2026 following a search conducted by an independent recruitment consultancy.

 

Francesca Ecsery has over 30 years' experience working in both blue-chip companies and start-ups and has special expertise in multiplatform consumer marketing, branding and commercial strategies. She is a non-executive director of Haffner Energy S.A., Air France S.A. and Henderson High Income Trust plc.

 

Francesca was previously a non-executive director at F&C Investment Trust PLC, the Association of Investment Companies (AIC), Marshall Motor Holdings PLC, Share PLC and Good Energy Group PLC and has held various senior positions in consumer-focused industries including the digital, retail and leisure and travel sectors. Her previous executive roles include McKinsey, PepsiCo, Thorn EMI, Thomas Cook and STA Travel.

 

There are no other disclosures required to be made for Francesca Ecsery in respect of paragraphs UKLR 6.4.8R (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Francesca Ecsery, or her persons closely associated, has no interest in the shares of the Company.

 

Appointment of Chairman and Senior Independent Director

 

As set out in the Annual Report for the year ended 31 March 2025, Michael Hughes retired as Chairman of the Board and as a Director of the Company on 31 March 2026.

 

With effect from 1 April 2026, David Simpson is appointed Chairman of the Board, Andrew Robson is appointed Senior Independent Director and Irina Miklavchich is appointed Chair of the Management Engagement Committee.

 

 

For further information, please contact:

 

Stuart Reid

abrdn Holdings Limited

Secretaries

 

Email:  cef.cosec@aberdeenplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJBMFTMTBJBRF
Date   Source Headline
26th Feb 20265:12 pmRNSTransaction in Own Shares
26th Feb 202612:25 pmRNSNet Asset Value(s)
25th Feb 202612:08 pmRNSNet Asset Value(s)
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 20263:53 pmRNSHolding(s) in Company
23rd Feb 202612:38 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 20265:03 pmRNSTransaction in Own Shares
20th Feb 20263:41 pmRNSHolding(s) in Company
20th Feb 202611:19 amRNSHolding(s) in Company
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 20265:07 pmRNSTransaction in Own Shares
19th Feb 202612:21 pmRNSNet Asset Value(s)
18th Feb 20265:09 pmRNSTransaction in Own Shares
18th Feb 202611:00 amRNSNet Asset Value(s)
17th Feb 20265:07 pmRNSTransaction in Own Shares
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20265:10 pmRNSTransaction in Own Shares
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:40 amRNSPortfolio disclosure
13th Feb 20265:09 pmRNSTransaction in Own Shares
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 20265:06 pmRNSTransaction in Own Shares
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 20265:06 pmRNSTransaction in Own Shares
11th Feb 202612:22 pmRNSNet Asset Value(s)
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20265:10 pmRNSTransaction in Own Shares
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
5th Feb 20269:36 amRNSDirector/PDMR Shareholding
4th Feb 20265:07 pmRNSTransaction in Own Shares
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 20265:12 pmRNSTransaction in Own Shares
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20265:04 pmRNSTransaction in Own Shares
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 202610:09 amRNSTotal Voting Rights
30th Jan 20265:09 pmRNSTransaction in Own Shares
30th Jan 20263:38 pmRNSHolding(s) in Company
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 20265:21 pmRNSTransaction in Own Shares
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 20265:23 pmRNSTransaction in Own Shares
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 20265:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.